Breaking News Instant updates and real-time market news.

TSLA

Tesla

$204.03

3.33 (1.66%)

14:26
10/02/16
10/02
14:26
10/02/16
14:26

Tesla backs outlook for 50,000 deliveries in 2H

TSLA Tesla
$204.03

3.33 (1.66%)

09/23/16
UBSW
09/23/16
NO CHANGE
Target $160
UBSW
Sell
Tesla not a preferred car in high income homes, says UBS
UBS analyst Colin Langan said his survey of high income households shows they prefer other luxury car makers over Tesla. The results showed there is stiff competition with other brands causing Langan to remain cautious on Tesla. Langan reiterated his Sell rating and $160 price target on Tesla shares.
09/26/16
BARD
09/26/16
NO CHANGE
Target $25
BARD
Neutral
SolarCity deal spread offers short-term trading opportunity, says Baird
Baird analyst Ben Kallo noted the "substantial" spread between SolarCity's (SCTY) share price and Tesla's (TSLA) acquisition price and sees it as a short-term trading opportunity as he is increasingly confident that their deal will close, pinning an 80% probability on the chance that the merger occurs. Kallo keeps a Neutral rating and $25 price target on SolarCity shares.
09/28/16
PACS
09/28/16
NO CHANGE
PACS
Outlook mixed for Tesla, says Pacific Crest
After conducting checks, Pacific Crest analyst Brad Erickson says that orders for Tesla's Model X have improved, and he expects the company's Q3 deliveries to be "solid." However, he believes that the company is offering "aggressive" discounts on Model 3 vehicles, and he thinks the company "faces overall ASP and margin risk," along with a questionable long-term demand outlook. Erickson remains cautious on the stock and keeps a Sector Weight rating on the shares.
09/28/16
BARD
09/28/16
NO CHANGE
Target $338
BARD
Outperform
Baird estimates Tesla to report 21,000 deliveries for Q3
Baird analyst Ben Kallo said he expects Tesla (TSLA) to report its Q3 delivery figures by early next week, possibly on Monday, October 3, and he estimates the company will report 21,000 total deliveries, including 12,000 Model S deliveries and 9,000 Model X deliveries. Kallo thinks a delivery number above 20,000 vehicles will be viewed as positive and believes "shorts may return" to Tesla after the delivery announcement as the company's acquisition of SolarCity (SCTY)progresses. The analyst keeps an Outperform rating and $338 price target on Tesla shares.

TODAY'S FREE FLY STORIES

XLE

Energy Select Sector SPDR

$64.14

-0.1 (-0.16%)

08:19
06/28/17
06/28
08:19
06/28/17
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$35.09

-0.91 (-2.53%)

08:19
06/28/17
06/28
08:19
06/28/17
08:19
Earnings
Chemours raises 2017 adjusted EBITDA view to 'above $1.25B' »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$89.13

-0.71 (-0.79%)

08:19
06/28/17
06/28
08:19
06/28/17
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$53.68

-0.33 (-0.61%)

08:19
06/28/17
06/28
08:19
06/28/17
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$52.97

-0.6 (-1.12%)

08:18
06/28/17
06/28
08:18
06/28/17
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$55.23

-0.48 (-0.86%)

08:18
06/28/17
06/28
08:18
06/28/17
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDXG

Interpace Diagnostics

$0.85

-0.043 (-4.82%)

, AET

Aetna

08:18
06/28/17
06/28
08:18
06/28/17
08:18
Hot Stocks
Interpace Diagnostics announces national contract with Aetna »

Interpace Diagnostics…

IDXG

Interpace Diagnostics

$0.85

-0.043 (-4.82%)

AET

Aetna

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBIO

Catalyst Biosciences

$4.47

-0.07 (-1.54%)

08:18
06/28/17
06/28
08:18
06/28/17
08:18
Hot Stocks
Catalyst granted orphan product designation for hemophilia B candidate in Europe »

Catalyst Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

XLV

Health Care Select Sector SPDR

$79.66

-0.73 (-0.91%)

08:18
06/28/17
06/28
08:18
06/28/17
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$139.84

-1.24 (-0.88%)

08:18
06/28/17
06/28
08:18
06/28/17
08:18
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$212.93

-0.94 (-0.44%)

08:17
06/28/17
06/28
08:17
06/28/17
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$241.33

-1.96 (-0.81%)

08:17
06/28/17
06/28
08:17
06/28/17
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$24.14

0.12 (0.50%)

08:17
06/28/17
06/28
08:17
06/28/17
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$82.90

-2.44 (-2.86%)

08:16
06/28/17
06/28
08:16
06/28/17
08:16
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NGVT

Ingevity

$53.69

-0.86 (-1.58%)

08:16
06/28/17
06/28
08:16
06/28/17
08:16
Hot Stocks
Ingevity to construct activated carbon extrustion plant in China »

Ingevity Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

QQQ

PowerShares QQQ Trust

$138.03

-2.55 (-1.81%)

08:16
06/28/17
06/28
08:16
06/28/17
08:16
Technical Analysis
PowerShares QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$COMP

Nasdaq Composite

08:16
06/28/17
06/28
08:16
06/28/17
08:16
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDX

Nasdaq 100 Index

$5,671.60

-105.98995 (-1.83%)

08:16
06/28/17
06/28
08:16
06/28/17
08:16
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTMX

CytomX Therapeutics

$14.45

-0.45 (-3.02%)

08:15
06/28/17
06/28
08:15
06/28/17
08:15
Hot Stocks
CytomX Therapeutics treats first patient in Phase 1/2 PROCLAIM-CX-2009 trial »

CytomX Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:15
06/28/17
06/28
08:15
06/28/17
08:15
General news
Energy Action: NYMEX »

Energy Action: NYMEX…

08:15
06/28/17
06/28
08:15
06/28/17
08:15
General news
International Trade in Goods Balance to be reported at 08:30 »

May International Trade…

LNCE

Snyder's-Lance

$34.88

-1.27 (-3.51%)

08:14
06/28/17
06/28
08:14
06/28/17
08:14
Hot Stocks
Snyder's-Lance appoints Brian Driscoll as CEO »

Snyder's-Lance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MON

Monsanto

$117.25

-0.55 (-0.47%)

08:14
06/28/17
06/28
08:14
06/28/17
08:14
Earnings
Monsanto sees FY17 ongoing EPS $4.50-$4.90, consenus $4.89 »

The company confirms EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

MON

Monsanto

$117.25

-0.55 (-0.47%)

, BAYRY

Bayer

$137.59

0.89 (0.65%)

08:14
06/28/17
06/28
08:14
06/28/17
08:14
Earnings
Monsanto reports Q3 ongoing EPS $1.93, consensus $1.76 »

Reports Q3 revenue…

MON

Monsanto

$117.25

-0.55 (-0.47%)

BAYRY

Bayer

$137.59

0.89 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

TYG

Tortoise Energy

$29.13

-0.14 (-0.48%)

08:13
06/28/17
06/28
08:13
06/28/17
08:13
Upgrade
Tortoise Energy rating change  »

Tortoise Energy upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.